Owens & Minor rebrands after $375M sale of largest division

Henrico County-based Fortune 500 health care logistics and supply company Owens & Minor on Wednesday completed the divestiture of its Products & Healthcare Services segment and the Owens & Minor brand to California-based private equity firm Platinum Equity for $375 million, as it simultaneously rebranded its publicly traded parent company as Accendra Health.

The name change affects only the parent corporation, not its subsidiaries. Accendra Health will continue to operate its Apria and Byram health care brands.

Accendra Health (then Owens & Minor) first announced the agreement to sell its Products & Healthcare Services segment, along with the Owens & Minor brand, on Oct. 7, 2025. The sale reduces the corporation’s size, allowing it to focus on its Patient Direct service, a profitable sector that provides home medical equipment.

“Today’s announcement marks an inflection point in the strategic transformation of Owens & Minor into Accendra Health, a leading nationwide pure play home based care platform,”Accendra President and CEO Edward A. Pesicka said in a statement. “The completion of the sale of the P&HS segment enables the company to become a more focused and resilient organization that is well equipped to deliver on our commitment to supporting patients with chronic conditions by providing what they need for home-based care.”

As part of the transaction, the company will retain a 5% interest in the P&HS sector, as well as certain tax assets that exceed $150 million.

Based in Beverly Hills, California, Platinum Equity has regional offices worldwide and manages four private equity fund vehicles. The company has invested in multiple health care and supply businesses over its 30-year history.

Accendra Health’s common stock began trading today on the New York Stock exchange under its new name and ticker symbol, ACH.

“We’re energized by what lies ahead and are confident that our comprehensive product portfolio, expansive payor contracts, and national footprint position us advantageously for the future evolution of home-based care,” said Pesicka in a statement. “With Accendra’s full attention dedicated to our Apria and Byram brands, our capital deployment, corporate strategy, and operational execution are focused and aligned to support durable growth and create long-term value.”

Accendra Health and Platinum Equity did not immediately return requests for comment.

Accendra Health reported $10.7 billion in fiscal 2024 revenue, up from $10.3 billion in 2023.